Deep convolutional generative adversarial network for Alzheimer's disease classification using positron emission tomography (PET) and synthetic data augmentation
Related Experiment Video
Updated: Oct 29, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Muhammad Sajjad1, Farheen Ramzan2, Muhammad Usman Ghani Khan1,2
1National Center of Artificial Intelligence (NCAI), Al-Khawarizmi Institute of Computer Science (KICS), University of Engineering and Technology (UET), Lahore, Pakistan.
Abstract:
With the evolution of deep learning technologies, computer vision-related tasks achieved tremendous success in the biomedical domain. For supervised deep learning training, we need a large number of labeled datasets. The task of achieving a large number of label dataset is a challenging. The availability of data makes it difficult to achieve and enhance an automated disease diagnosis model's performance. To synthesize data and improve the disease diagnosis model's accuracy, we proposed a novel approach for the generation of images for three different stages of Alzheimer's disease using deep convolutional generative adversarial networks. The proposed model out-perform in synthesis of brain positron emission tomography images for all three stages of Alzheimer disease. The three-stage of Alzheimer's disease is normal control, mild cognitive impairment, and Alzheimer's disease. The model performance is measured using a classification model that achieved an accuracy of 72% against synthetic images. We also experimented with quantitative measures, that is, peak signal-to-noise (PSNR) and structural similarity index measure (SSIM). We achieved average PSNR score values of 82 for AD, 72 for CN, and 73 for MCI and SSIM average score values of 25.6 for AD, 22.6 for CN, and 22.8 for MCI.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

